Drug Type Small molecule drug |
Synonyms Felbinac (JP17/USAN/INN), Felbinac tape, Felbinac transdermal + [18] |
Target |
Action inhibitors |
Mechanism COX inhibitors(Cyclooxygenases inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (25 Sep 1986), |
Regulation- |
Molecular FormulaC14H12O2 |
InChIKeyQRZAKQDHEVVFRX-UHFFFAOYSA-N |
CAS Registry5728-52-9 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Low Back Pain | Japan | 28 Feb 1989 | |
| Bursitis | Japan | 25 Sep 1986 | |
| Musculoskeletal Pain | Japan | 25 Sep 1986 | |
| Osteoarthritis | Japan | 25 Sep 1986 | |
| Post-traumatic pain | Japan | 25 Sep 1986 | |
| Tenosynovitis | Japan | 25 Sep 1986 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Osteoarthritis | Phase 2 | China | 21 Jan 2014 | |
| Soft Tissue Injuries | Phase 2 | China | 15 Nov 2011 |





